Trial Profile
The induction agent effect on BK viremia in renal and pancrease transplant patients.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 30 Sep 2011
Price :
$35
*
At a glance
- Drugs Basiliximab (Primary) ; Antithymocyte globulin; Corticosteroid; Corticosteroids; Mycophenolate sodium; Tacrolimus
- Indications Pancreas transplant rejection; Renal transplant rejection
- Focus Adverse reactions
- 15 Sep 2011 Trial phase changed from II to IV as reported by ClinicalTrials.gov.
- 15 Sep 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 21 Jan 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.